http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108888621-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10
filingDate 2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108888621-B
titleOfInvention Application of levo-stepholidine in preparing medicine for inhibiting myopia and use method thereof
abstract An application of levo-stepholidine in preparing the medicine for suppressing myopia and its application method features that the levo-stepholidine (L-SPD) in stephania sinica is used to activate D1 receptor and antagonize D2 receptor, so suppressing the elongation of vitreous cavity and axis in the process of shape deprivation myopia and suppressing the experimental myopia of animal.
priorityDate 2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593433

Total number of triples: 22.